Cancer Letters
Volume 210, Issue 1 , Pages 1-6 , 8 July 2004

Antiproliferative crude soy saponin extract modulates the expression of IκBα, protein kinase C, and cyclooxygenase-2 in human colon cancer cells

  • Hwa-Young Kim

      Affiliations

    • Department of Food and Nutrition, Sookmyung Women's University, 53-12 Chungpa-Dong, 2-ka, Yongsan-ku, Seoul 140-742, South Korea
    • ,
  • Rina Yu

      Affiliations

    • Department of Food and Nutrition, University of Ulsan, Ulsan, South Korea
    • ,
  • Jeong-Sang Kim

      Affiliations

    • Department of Animal Science and Biotechnology, Kyungpook National University, Daegu, South Korea
    • ,
  • Young-Kyoon Kim

      Affiliations

    • Department of Forestry Products, Kookmin University, Seoul, South Korea
    • ,
  • Mi-Kyung Sung

      Affiliations

    • Department of Food and Nutrition, Sookmyung Women's University, 53-12 Chungpa-Dong, 2-ka, Yongsan-ku, Seoul 140-742, South Korea
    • Corresponding Author InformationCorresponding author. Tel./fax.: +82-2-710-9395

Received 5 September 2003 ,Revised 21 October 2003 ,Accepted 12 January 2004.

References 

  1. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 1994;21:113–131
  2. Messina M, Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 1991;83:541–546
  3. Seeman P. Ultrastructure of membrane lesions in immune lysis, osmotic lysis and drug-induced lysis. Fed. Proc. 1974;33:2116–2124
  4. Gestetner B, Birk Y, Tencer Y. Soybean saponins. Fate of ingested soybean saponins and the physiological aspect of their hemolytic activity. J. Agric. Food Chem. 1968;16:1031–1035
  5. Bae EA, Han MJ, Choo MK, Park SY, Kim DH. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 2002;25:58–63
  6. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenosides Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998;50:1155–1160
  7. Fenwick DE, Oakenfull D. Saponin content of soybeans and some commercial soybean products. J. Sci. Food Agric. 1981;32:273–278
  8. Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins, isoflavones related to soybean processing. J. Nutr. 1995;125:581S–588S
  9. Sung M-K, Kendall CWC, Koo MM, Rao AV. Effect of soybean saponins and gypsophilla saponin on growth and viability of colon carcinoma cells in culture. Nutr. Cancer. 1995;23:259–270
  10. Koratkar R, Rao AV. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer. 1997;27:206–207
  11. Oh Y-J, Sung M-K. Soybean saponins inhibit cell proliferation by suppression PKC activation and induce differentiation of HT-29 human colon adenocarcinoma cells. Nutr. Cancer. 2001;39:132–138
  12. Castagma M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, et al.  Direct activation of calcium-activated, phospholipid-dependent protein kinase C by tumor-promoting phorbol ester. J. Biol. Chem. 1982;257:7847–7851
  13. Bruce WR, Giacca A, Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol. Biomark. Prev. 2000;9:1271–1279
  14. Dannhardt G, Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. Eur. J. Med. Chem. 2001;36:109–126
  15. Surh Y-J, Chun K-S, Chan H-H, Han S-S, Keum Y-S, Park K-K, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NFκB activation. Mutat. Res. 2001;480:243–268
  16. Lee H-W, Ahn D-H, Crawley SC, Li J-D, Gum JR, Basbaum CB, et al.  Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-κB. J. Biol. Chem. 2002;277:32624–32631
  17. Wolf WJ, Thomas BW. Thin layer and anion exchange chromatography of soybean saponins. J. Am. Oil Chem. Soc. 1970;47:86–90
  18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein of dye binding. Anal. Biochem. 1976;72:248–254
  19. Thun MJ. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metast. Rev. 1994;13:269–277
  20. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willet WC, et al. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 1995;333:609–614
  21. Williams CS, Smalley W, Dubois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest. 1997;100:1325–1329
  22. Reddy BS, Rao CV. Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging. 2000;16:329–334
  23. Boland CR, Sinicrope FA, Brenner DE, Carethers JM. Colorectal cancer prevention and treatment. Gastroenterology. 2000;118:S115–S128
  24. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 1998;58:409–412
  25. Roy HK, Karolski WJ, Ratashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int. J. Cancer. 2001;92:609–615
  26. Barnes CJ, Cameron IL, Hardman WE, Lee M. Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br. J Cancer. 1998;77:573–580
  27. Kawai N, Tsujii M, Tsuji S. Cyclooxygenases and colon cancer. Prostaglandins Other Lipid. Mediat. 2002;68–69:187–196
  28. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA. 1996;93:4816–4820
  29. Williams C, Shattuck-Brandt RL, DuBois RN. The role of COX-2 in intestinal cancer. Ann. NY Acad. Sci. 1999;889:72–83
  30. Dempke W, Rie C, Grothey A, Schmol HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy ?. J. Cancer Res. Clin. Oncol. 2001;127:411–417
  31. Li X, Stark GR. NFκB-dependent signaling pathways. Exp. Hematol. 2002;30:285–296
  32. Marks F, Fürstenberger G. Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur. J. Cancer. 2000;36:314–329
  33. Marks F, Fürstenberger G. Eicosanoids and cancer. In:  Marks F,  Fürstenberger G editor. Prostaglandins, leukotrienes and other eicosanoids: from biogenesis to clinical application. Weinheim: Wiley–VHC; 1999;p. 303–330
  34. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12:274–277
  35. Jun H-S, Kim S-E, Sung M-K. Protective effect of soybean saponins and major antioxidants against aflatoxin B1-induced mutagenicity and DNA-adduct formation. J. Med. Food. 2002;5:235–240
  36. Yoshiki Y, Okubo K. Active oxygen scavenging activity of DDMP (2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one) saponin in soybean seed. Biosci. Biotech. Biochem. 1995;59:1556–1557

PII: S0304-3835(04)00054-0

doi: 10.1016/j.canlet.2004.01.009

Cancer Letters
Volume 210, Issue 1 , Pages 1-6 , 8 July 2004

Article Tools

* Image Usage & Resolution